Aims: The human NRCAM gene is associated with polysubstance use. Nrcam knockout mice do not acquire a preference for addictive substances. We aimed to elucidate the role of Nrcam in specific neural circuits underlying congenital preference for substances and the acquisition of addiction.
To elucidate the precise molecular mechanisms that contribute to addiction-related cognitive and behavioral characteristics, transcriptomic analyses using Nrcam knockout mice could be useful.
Using microarray, we evaluated the differences in gene expression in the brain that were related to polysubstance use, either in the naïve brain in which drug preference has not developed, or in the "acquired brain" after the development of drug addiction. Several molecules could act as shared factors in the acquisition of both METH and COC preference; there would also be some nonshared factors. Although many genes have been identified as candidate vulnerability genes by microarray analyses, we focused on monoaminergic, glutamatergic, and GABAergic molecules that have been investigated for associations with the substance use of METH and COC.
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2 | MATERIALS AND METHODS
| Subjects
Nrcam knockout mice, developed by Sakurai et al, 12 were used in this study. The mice were housed under a 12-hour light/12-hour dark cycle (lights off from 19:00 to 07:00) and given access to food and water ad libitum. Heterozygous sibling mating pairs were obtained from the same litter and used as breeding pairs to produce cohorts used in this study. None of the three genotypes was lethal; however, because no human has a complete deficit of the NRCAM gene, (Tables S1-S12) . Among these candidates, we failed to replicate the differential expression observed in the microarray analysis when we used TaqMan geneexpression analysis for the following genes: dopamine D5 receptor (Drd5), glutamine receptor and ionotropic kainite 3 (Grik3), and vesicular glutamate transporter (Vglut1, Slc17a7).
Glutaminase (Gls) was expressed at lower levels in brains from
Het mice than in those from W naïve mice, as reported in our previous study 2 The expression in the striatum of the Het mice was lower than that in the striatum of the W mice after treatment with METH (1,30) = 5.9, P = 0.022, Figure 3B ).
In the analysis of the midbrain, the first screening using microar- Figure 4B ). 
| DISCUSSION
NrCAM is a cell adhesion molecule that modulates several neural processes including neurogenesis, neurite outgrowth, and synaptogenesis. 13 Although the exact role of NrCAM in cognition and behavior is still unknown, our previous study indicated that NrCAM was involved in addiction to morphine, amphetamine, COC, and alcohol, which could affect different neural systems. These findings imply that NrCAM regulates addiction-related neural systems, including glutamatergic, GABAergic, and monoaminergic systems, both during development and in the mature brain. Recent studies revealed that glutamate and GABA systems are affected by psychostimulants. 11, 14, 15 There may be a common molecular mechanism underlying the addiction to different substances; however, there may also be unique pathways, which may be regulated by NrCAM in the brain. NrCAM has a role in the development of addiction-related traits in both naive and "acquired brains," manifesting as behaviors that are associated with responses to novel stimuli, appetitive motivational states, anxiety, and possibly obsessive behavior, as indicated in our previous studies. Glutamate is the principal excitatory neurotransmitter in the brain and has effects on drug-seeking behaviors for COC. 11, 16 Further, glutamatergic and dopaminergic alterations in the brain are thought to contribute to the relatively long-lasting and recurrent nature of METH psychosis and depression. 17, 18 In previous studies in our laboratory, we found that Gls expression was reduced in cultured Grm2 mutant mice display altered emotionality, impulsivity, and riskrelated behaviors, and show significantly higher levels of alcohol consumption and preference than do wild type control mice. 20, 21 The levels of Grm2 expression in both the striatum and hippocampus have been shown to be significantly lower in alcohol preferring (P) rats than in nonpreferring (NP) rats. 22 Therefore, we hypothesized that Grm2 expression in the striatum would be lower in Nrcam Het mice than in W mice after METH or COC treatment. The results of the study could support the hypothesis by single-sided statistical analysis for METH and COC treatment (P < 0.01 and P = 0.03, Figure 2) . Thus, the reduction in Grm2 expression appears to be acquired after the development of addiction.
RNA-Seq analysis revealed that GABRG2 was downregulated in alcoholics and COC addicts, 23 while stem cells obtained from alcoholics showed an increase in GABRG2 expression after chronic treatment with alcohol. 24 Similar to a previous study indicating that
Gabrg2 expression was upregulated in P rats, 23 Gabrg2 expression was downregulated by COC in the Nrcam Het mice that showed less preference to addictive substances in this study. When these findings are taken together, Gabrg2 reduction appears to not be a congenital factor, but may instead be an acquired factor during the In addition, the analysis also indicated an involvement of Slc17a7 in COC addiction. A gene-expression network underlying alcoholism that involves recognized substrates for addiction, including SLC17A7, is known to be present in the hippocampus. However, analyses showed that this network was not conserved in COC users. 26 Further studies are needed to identify the exact role of the vesicular glutamate transporter in this type of addiction.
| CONCLUSION
This study supports the proposed involvement of several glutamater- 
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